Use of gabapentin in pain management

被引:26
作者
Wetzel, CH
Connelly, JF
机构
[1] N CAROLINA BAPTIST HOSP,DRUG INFORMAT SERV CTR,WINSTON SALEM,NC 27157
[2] CAMPBELL UNIV,SCH PHARM,BUIES CREEK,NC 27506
关键词
D O I
10.1177/106002809703100920
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There have been many proposed uses for gabapentin, including midscapular pain secondary to radiation myelopathy, RSD, neuropathic pain, postherpetic neuralgia, and migraine prophylaxis. However, the published reports consist of a small number of patients and limited data. Limited data provided in published case reports do not allow adequate evaluation of expected adverse effects or efficacy. It is unclear whether gabapentin is more effective for a specific type of pain and how gabapentin may compare with placebo or other therapeutic alternatives. Therefore, randomized, double-blind, placebo- controlled, prospective studies are warranted to further elucidate gabapentin uses beyond what is recommended by the Food and Drug Administration. Gabapentin should only be considered for pain management after well- established therapies have failed to produce desired outcomes.
引用
收藏
页码:1082 / 1083
页数:2
相关论文
共 8 条
[1]  
CHEVILLE A, 1995, PROGRAM BOOK AM PAIN, pA115
[2]  
Mathew Ninan T., 1996, Neurology, V46, pA169
[3]   GABAPENTIN IN THE MANAGEMENT OF REFLEX SYMPATHETIC DYSTROPHY [J].
MELLICK, GA ;
MELLICY, LB ;
MELLICK, LB .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (04) :265-266
[4]  
MELLICK GA, 1995, AM J PAIN MANAGEMENT, V5, P7
[5]   SUCCESSFUL TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY WITH GABAPENTIN [J].
MELLICK, LB ;
MELLICK, GA .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1995, 13 (01) :96-96
[6]   Gabapentin adjunctive therapy in neuropathic pain states [J].
Rosner, H ;
Rubin, L ;
Kestenbaum, A .
CLINICAL JOURNAL OF PAIN, 1996, 12 (01) :56-58
[7]   Gabapentin as a novel treatment for postherpetic neuralgia [J].
Segal, AZ ;
Rordorf, G .
NEUROLOGY, 1996, 46 (04) :1175-1176
[8]   PAIN MECHANISMS AND MANAGEMENT - AN UPDATE [J].
SIDDALL, PJ ;
COUSINS, MJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (10) :679-688